Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−239.73 M USD
1.80 M USD
9.99 M
About Inhibrx Biosciences, Inc.
Sector
Industry
CEO
Mark Paul Lappe
Website
Headquarters
La Jolla
Founded
2024
FIGI
BBG01MS5Q9G3
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded on January 8, 2024 and is headquartered in La Jolla, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INBX is 13.98 USD — it has decreased by −1.75% in the past 24 hours. Watch Inhibrx Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inhibrx Biosciences, Inc. stocks are traded under the ticker INBX.
INBX stock has fallen by −15.98% compared to the previous week, the month change is a −11.35% fall, over the last year Inhibrx Biosciences, Inc. has showed a −30.03% decrease.
We've gathered analysts' opinions on Inhibrx Biosciences, Inc. future price: according to them, INBX price has a max estimate of 15.00 USD and a min estimate of 15.00 USD. Watch INBX chart and read a more detailed Inhibrx Biosciences, Inc. stock forecast: see what analysts think of Inhibrx Biosciences, Inc. and suggest that you do with its stocks.
INBX reached its all-time high on Dec 18, 2020 with the price of 50.97 USD, and its all-time low was 7.67 USD and was reached on Jun 16, 2022. View more price dynamics on INBX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INBX stock is 7.22% volatile and has beta coefficient of 1.09. Track Inhibrx Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Inhibrx Biosciences, Inc. there?
Yes, you can track Inhibrx Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Inhibrx Biosciences, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
INBX earnings for the last quarter are −2.84 USD per share, whereas the estimation was −3.38 USD resulting in a 15.98% surprise. The estimated earnings for the next quarter are −2.88 USD per share. See more details about Inhibrx Biosciences, Inc. earnings.
Inhibrx Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
INBX net income for the last quarter is −43.86 M USD, while the quarter before that showed 1.86 B USD of net income which accounts for −102.36% change. Track more Inhibrx Biosciences, Inc. financial stats to get the full picture.
No, INBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inhibrx Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inhibrx Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inhibrx Biosciences, Inc. stock shows the sell signal. See more of Inhibrx Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.